[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
September 1961

The Regulation of Pancreatic Secretion by Serotonin

Author Affiliations

Buswell Fellow in Surgical Research (Dr. Drapanas).; From the Department of Surgery, University of Buffalo School of Medicine, and the Edward J. Meyer Memorial Hospital.

Arch Surg. 1961;83(3):462-466. doi:10.1001/archsurg.1961.01300150136018

Although a significant amount of the serotonin (5-hydroxytryptamine) in the body exists in tissue-bound form, predominantly in the mucosa of the gastrointestinal tract, the brain, and to a less extent in the platelets, no definite physiologic role has been assigned to this interesting active amine except in the malignant carcinoid syndrome. Recently, however, serotonin has also been implicated as a physiologic regulatory substance in intestinal motor activity2 and in gastric secretion.1,9

In preliminary experiments in our laboratory it was established that serotonin and serotonin precursor (5-hydroxytryptophane) produce a significant depression of pancreatic secretion in dogs with chronic pancreatic fistulas, suggesting that these substances may also play a physiologic role in the regulation of pancreatic secretion.

The present report deals with further studies of the physiology of pancreatic secretion and specifically of the mechanism of alteration of pancreatic secretion by serotonin.

Methods  Successful chronic total pancreatic fistulas were prepared